Cdt1 is differentially targeted for degradation by anticancer chemotherapeutic drugs.
BACKGROUND: Maintenance of genome integrity is crucial for the propagation of the genetic information. Cdt1 is a major component of the pre-replicative complex, which controls once per cell cycle DNA replication. Upon DNA damage, Cdt1 is rapidly targeted for degradation. This targeting has been sugg...
Main Authors: | Athanasia Stathopoulou, Vassilis Roukos, Chariklia Petropoulou, Panagiotis Kotsantis, Nickolas Karantzelis, Hideo Nishitani, Zoi Lygerou, Stavros Taraviras |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3316709?pdf=render |
Similar Items
-
Visualizing the dynamics of histone variants in the S-phase nucleus
by: Stella Maxouri, et al.
Published: (2018-10-01) -
Cortical Development and Brain Malformations: Insights From the Differential Regulation of Early Events of DNA Replication
by: Argyro Kalogeropoulou, et al.
Published: (2019-03-01) -
Checkpoint kinase ATR phosphorylates Cdt2, a substrate receptor of CRL4 ubiquitin ligase, and promotes the degradation of Cdt1 following UV irradiation.
by: Hiroki Sakaguchi, et al.
Published: (2012-01-01) -
Ιn vivo imaging of DNA-bound minichromosome maintenance complex in embryonic mouse cortex
by: Maria Mougkogianni, et al.
Published: (2021-03-01) -
Whole transcriptome data analysis of mouse embryonic hematopoietic stem and progenitor cells that lack Geminin expression
by: Alexandra L. Patmanidi, et al.
Published: (2016-06-01)